Literature DB >> 16118116

RNA silencing of Cks1 induced G2/M arrest and apoptosis in human lung cancer cells.

Yi-Shan Tsai1, Hui-Chiu Chang, Lea-Yea Chuang, Wen-Chun Hung.   

Abstract

Cdc kinase subunit 1 (Cks1) has been shown to involve in the regulation of cell cycle progression and p27Kip1 degradation. To define the role of Cks1 in lung tumorigenesis, we examined the expression of Cks1 in human lung cancer cell lines and tested the effect of Cks1-specific small interfering RNA (siRNA) on these cells. Reverse transcriptase-polymerase chain reaction (RT-PCR) and western blot analysis showed that Cks1 was highly expressed in human lung cancer cells. Transfection of Cks1 siRNA down-regulated Cdc2 kinase activity and induced G2/M arrest in Cks1- overexpressing H358 lung cancer cells. Long-term treatment of Cks1 siRNA induced caspase activation and apoptosis in H358 cells. On the contrary, Cks1 siRNA did not affect viability of normal human lung fibroblasts under the same experimental condition. Collectively, our results suggest that Cks1 participates in the steps of lung tumorigenesis and this gene may be a target for the treatment of lung cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16118116     DOI: 10.1080/15216540500215531

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  11 in total

1.  MicroRNAomic Transcriptomic Analysis Reveal Deregulation of Clustered Cellular Functions in Human Mesenchymal Stem Cells During in Vitro Passaging.

Authors:  Shuh-Wen Aung; Noor Hayaty Abu Kasim; Shamsul Azlin Ahmad Shamsuddin; Thamil Selvee Ramasamy
Journal:  Stem Cell Rev Rep       Date:  2020-02       Impact factor: 5.739

2.  CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27Kip1-dependent and -independent mechanisms.

Authors:  Fenghuang Zhan; Simona Colla; Xiaosong Wu; Bangzheng Chen; James P Stewart; W Michael Kuehl; Bart Barlogie; John D Shaughnessy
Journal:  Blood       Date:  2007-02-15       Impact factor: 22.113

3.  MicroRNA-940 inhibits glioma cells proliferation and cell cycle progression by targeting CKS1.

Authors:  Hui Luo; Ran Xu; Binglin Chen; Shiyang Dong; Fengqi Zhou; Tianfu Yu; Guanhua Xu; Junxia Zhang; Yingyi Wang; Yongping You
Journal:  Am J Transl Res       Date:  2019-08-15       Impact factor: 4.060

4.  On the statistical assessment of classifiers using DNA microarray data.

Authors:  N Ancona; R Maglietta; A Piepoli; A D'Addabbo; R Cotugno; M Savino; S Liuni; M Carella; G Pesole; F Perri
Journal:  BMC Bioinformatics       Date:  2006-08-19       Impact factor: 3.169

5.  Cks1: Structure, Emerging Roles and Implications in Multiple Cancers.

Authors:  Vinayak Khattar; Jaideep V Thottassery
Journal:  J Cancer Ther       Date:  2013-10-01

6.  The clinical relevance of the miR-197/CKS1B/STAT3-mediated PD-L1 network in chemoresistant non-small-cell lung cancer.

Authors:  Yu Fujita; Shigehiro Yagishita; Keitaro Hagiwara; Yusuke Yoshioka; Nobuyoshi Kosaka; Fumitaka Takeshita; Tomohiro Fujiwara; Koji Tsuta; Hiroshi Nokihara; Tomohide Tamura; Hisao Asamura; Makoto Kawaishi; Kazuyoshi Kuwano; Takahiro Ochiya
Journal:  Mol Ther       Date:  2015-01-19       Impact factor: 11.454

7.  CKS1 expression in melanocytic nevi and melanoma.

Authors:  Anna A Brożyna; Andrew Aplin; Cynthia Cohen; Grant Carlson; Andrew Joseph Page; Michael Murphy; Andrzej T Slominski; J Andrew Carlson
Journal:  Oncotarget       Date:  2017-12-23

8.  PADI3 plays an antitumor role via the Hsp90/CKS1 pathway in colon cancer.

Authors:  Zhengbin Chai; Li Wang; Yabing Zheng; Na Liang; Xiwei Wang; Yingying Zheng; Zhiwei Zhang; Chuanxi Zhao; Tingting Zhu; Chunyan Liu
Journal:  Cancer Cell Int       Date:  2019-11-05       Impact factor: 5.722

Review 9.  Loss of cks1 homeostasis deregulates cell division cycle.

Authors:  Anand Krishnan; S Asha Nair; M Radhakrishna Pillai
Journal:  J Cell Mol Med       Date:  2009-02-17       Impact factor: 5.310

10.  Cyclin-Dependent Kinase Regulatory Subunit 2 Indicated Poor Prognosis and Facilitated Aggressive Phenotype of Hepatocellular Carcinoma.

Authors:  Jie Zhang; Qianqian Song; Jinxia Liu; Lina Lu; Yuqing Xu; Wenjie Zheng
Journal:  Dis Markers       Date:  2019-10-22       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.